Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 26, 2025

The Zacks Analyst Blog Wells Fargo, Bank of America and Citigroup

View original at finance.yahoo.com
The Zacks Analyst Blog Wells Fargo, Bank of America and Citigroup For Immediate Releases Chicago, IL – December 26, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Citigroup carries Zacks Rank #3 (Hold)

    80% confidence
  • Plans to open more than 150 financial centers by 2027

    80% confidence
  • Aims to deliver more than 12% earnings growth over the next three to five years

    80% confidence
  • 2025 net interest income (NII) expected to be stable year over year

    80% confidence
  • Bank of America carries Zacks Rank #3 (Hold)

    80% confidence
  • Successfully exited consumer banking businesses in nine countries

    80% confidence
  • Zacks Consensus Estimate for Bank of America 2025 and 2026 earnings suggests year-over-year increases of 15.9% and 14% respectively

    80% confidence
  • Target ROTCE between 16% and 18% while maintaining Common Equity Tier 1 ratio of 10.5%

    80% confidence
  • Future interest rate moves will remain highly dependent on incoming economic data

    80% confidence
  • Zacks Consensus Estimate for Citigroup 2025 and 2026 earnings indicate year-over-year growth of 27.6% and 32.4% respectively

    80% confidence
  • Zacks Consensus Estimate for Wells Fargo 2025 and 2026 earnings implies year-over-year growth rates of 16.8% and 11.9% respectively

    80% confidence
  • NII expected to grow 5-7% in 2026, after similar growth in 2025

    80% confidence
  • Wells Fargo carries Zacks Rank #3 (Hold)

    80% confidence
  • 2025 NII projected to rise 5.5% year over year

    80% confidence
  • Total revenues expected to exceed $84 billion in 2025

    80% confidence
  • Revenues projected to see 4-5% CAGR through 2026

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
The Zacks Analyst Blog Wells Fargo, Bank of America and Citigroup — Source | Via News | Finance Via News